Aymen Shamkhani-Al

Tremona Road
Southampton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Immune-epithelial crosstalk governs immune checkpoint inhibitor efficacy in colorectal cancer.

Immune-epithelial crosstalk governs immune checkpoint inhibitor efficacy in colorectal cancer.

Journal: iScience

Published: July 29, 2025

CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial.

CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 29, 2025

The ELECTRA Trial: Approach to Contemporary Challenges in the Development and Implementation of Double-Blinded, Randomised, Controlled Clinical Trials in Low-Volume High-Complexity Surgical Oncology.

The ELECTRA Trial: Approach to Contemporary Challenges in the Development and Implementation of Double-Blinded, Randomised, Controlled Clinical Trials in Low-Volume High-Complexity Surgical Oncology.

Journal: Cancers

Published: December 24, 2024

Harnessing multivalency and FcγRIIB engagement to augment anti-CD27 immunotherapy.

Harnessing multivalency and FcγRIIB engagement to augment anti-CD27 immunotherapy.

Journal: Nature communications

Published: December 10, 2024

Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges.

Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 08, 2023

Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc.

Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc.

Journal: Frontiers in immunology

Published: July 03, 2023

Fcγ receptor-mediated cross-linking codefines the immunostimulatory activity of anti-human CD96 antibodies.

Fcγ receptor-mediated cross-linking codefines the immunostimulatory activity of anti-human CD96 antibodies.

Journal: JCI insight

Published: January 12, 2022

Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.

Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.

Journal: Journal for immunotherapy of cancer

Published: April 08, 2021

Domain binding and isotype dictate the activity of anti-human OX40 antibodies.

Domain binding and isotype dictate the activity of anti-human OX40 antibodies.

Journal: Journal for immunotherapy of cancer

Published: November 24, 2020

CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma.

CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma.

Journal: Journal for immunotherapy of cancer

Published: November 20, 2020

NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors.

NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors.

Journal: Cancer research

Published: October 10, 2019

Immuno-oncology for surgeons.

Immuno-oncology for surgeons.

Journal: The British journal of surgery

Published: January 22, 2019

Showing 1-12 of 34

Last Updated: 09/26/2026